January saw almost every major cardiovascular subspecialty represented among our most-clicked stories of the month.

An early pioneer in the interventional community, Hildner advocated for sharing experiences to improve patient outcomes.

Treatment at a high-volume center mitigated the risk, prompting questions about what these hospitals are doing better.

Watching a football game on TV today means facing a barrage of snacks and meals loaded with calories, salt, and fat.

The Cube CYP2C19 test can be used to aid clinicians in determining therapeutic strategy for drugs metabolized by the CYP450 2C19 genetic pathway. Genomadix CubeTM CYP2C19 System identifies the CYP2C19 ...

The immediate impact for the medical sciences is unclear, but the symbolism is “very chilling,” one commentator says.

Insight from almost 100,000 cases at a single institution show physician practice can make a difference, even without new ...

Obesity influences the thresholds, but even in nonobese patients with dyspnea, optimal cutoffs may be lower than recommended.

A maladaptive stress response might be amenable to behavioral or other interventions to lower future CV risk, say researchers ...

This year’s report shows risk factors on the rise, enduring racial and geographic gaps, and clues to the global picture, too.

These latest data reinforce years of smaller studies, but whether they should change practice is a matter of debate.

Task force members say that continued collection of data will help build credibility of what is “fair market value” for ...